Basecamp Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.23M Sell
4,700
-3,022
-39% -$775K 0.28% 31
2026
Q2
$1.94M Sell
7,722
-2
-0% -$430 0.36% 31
2026
Q1
$1.68M Sell
7,724
-16
-0.2% -$3.55K 0.35% 29
2025
Q4
$1.77M Buy
+7,740
New +$1.76M 0.38% 26

Other funds holding ABBV

Basecamp Wealth Advisors's ABBV Position: Q3 2026 in Review

Basecamp Wealth Advisors reduced its AbbVie (ABBV) stake by 39% in Q3 2026, selling an estimated $775K and leaving 4,700 shares worth $1.23M. The position accounts for 0.28% of the portfolio, ranked #31.

Basecamp Wealth Advisors first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.94M in Q2 2026. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Basecamp Wealth Advisors held 4,700 shares of AbbVie worth $1.23M as of Q3 2026.
  • Basecamp Wealth Advisors sold 3,022 AbbVie shares in Q3 2026, an estimated $775K.
  • AbbVie made up 0.28% of Basecamp Wealth Advisors's portfolio in Q3 2026, its #31 holding.
  • Basecamp Wealth Advisors first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Basecamp Wealth Advisors's AbbVie position peaked at $1.94M in Q2 2026.
  • 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.